Optimization of Chondrocyte Viability in Partially Decellularized Tracheal Grafts
Otolaryngology–Head and Neck Surgery · 2023
DOI: 10.1002/ohn.404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Maxwell Bergman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, The Ohio State University Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Chondrocytes, Trachea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Objective
Advancements in tissue‐engineered tracheal replacement (TETR) show promise for the use of partially decellularized tracheal grafts (PDTG) to address critical gaps in airway management and reconstruction. In this study, aiming to leverage the immunoprivileged nature of cartilage to preserve tracheal biomechanics, we optimize PDTG for retention of native chondrocytes. Study Design Comparison in vivo murine study.
Setting
Research Institute affiliated with Tertiary Pediatric Hospital.
Methods
PDTG were created per a shortened decellularization protocol using sodium dodecyl sulfate, then biobanked via cryopreservation technique. Decellularization efficiency was characterized by DNA assay and histology. Viability and apoptosis of chondrocytes in preimplanted PDTG and biobanked native trachea (control) was assessed with live/dead and apoptosis assays. PDTG (N = 5) and native trachea (N = 6) were orthotopically implanted in syngeneic recipients for 1‐month. At the endpoint, microcomputed tomography (micro‐CT) was employed to interrogate graft patency and radiodensity in vivo. Vascularization and epithelialization were qualitatively analyzed using histology images following explant.
Results
PDTG exhibited complete decellularization of all extra‐cartilaginous cells and reduced DNA content compared to control. Chondrocyte viability and nonapoptotic cell populations were improved utilizing biobanking and shorter decellularization time. All grafts remained patent. Evaluation of graft radiodensity at 1 month revealed elevation of Hounsfield units in both PDTG and native compared to host, with PDTG showing higher radiodensity than native. PDTG supported complete epithelialization and functional reendothelialization 1‐month postimplantation.
Conclusion
Optimizing PDTG chondrocyte viability is a key component to successful tracheal replacement. Ongoing research seeks to evaluate the acute and chronic immunogenicity of PDTG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, The Ohio State University Medical Center, Columbus, Ohio, USA.
- Department of Pediatric Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Center for Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.
ORCID-Profile: Maxwell Bergman
Förderung
- NHLBI NIH HHS
Zitieren
APA
Bergman, M., Harwood, J., Liu, L., Dharmadikhari, S., Shontz, K. M., & Chiang, T. (2023). Optimization of Chondrocyte Viability in Partially Decellularized Tracheal Grafts. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.404
Vancouver
Bergman M, Harwood J, Liu L, Dharmadikhari S, Shontz KM, Chiang T. Optimization of Chondrocyte Viability in Partially Decellularized Tracheal Grafts. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.404
BibTeX
@article{Bergman2023,
author = {Bergman, Maxwell and Harwood, Jacqueline and Liu, Lumei and Dharmadikhari, Sayali and Shontz, Kimberly M and Chiang, Tendy},
title = {Optimization of Chondrocyte Viability in Partially Decellularized Tracheal Grafts},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
doi = {10.1002/ohn.404}
}
EUVIMED